Actualités Medimmune (MM) - MEDI | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of...

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/...

MedImmune Receives Correspondence From FDA Regarding FluMist(R)

GAITHERSBURG, Md., May 25 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that the U.S. Food and Drug Administration...

MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations

Data Include Results from Phase 1 Studies with Monoclonal Antibody Targeting Interleukin-9 (IL-9); Preclinical Data Provide Further Rationale for...

FDA Advisory Committee Recommends Expanded Use of FluMist(R)

GAITHERSBURG, Md., May 16 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that the U.S. Food and Drug Administration's...

Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings

New Economic Analyses of School and Daycare Study Outcomes Suggest Vaccinating Against Influenza May Produce Cost Savings for Community at Large...

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di

- Numax Achieves Primary Endpoint Among High-Risk Infants Versus Current Standard of Care and Shows Reduction of Medically Attended Outpatient...

MedImmune and Pediatric Infectious Diseases Society Present 2007 Career Development Award and Viral Respiratory Disease Fellowsh

TORONTO, May 7 /PRNewswire-FirstCall/ -- The Pediatric Infectious Diseases Society (PIDS), supported by grants from MedImmune, Inc...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medimmune (MM) (MEDI)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MEDI Actualités

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Receives Correspondence From FDA Regarding FluMist(R)

MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations

FDA Advisory Committee Recommends Expanded Use of FluMist(R)

Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MedImmune Provides Fellowship Grants to Six Pediatric Respiratory Researchers

MedImmune and Pediatric Infectious Diseases Society Present 2007 Career Development Award and Viral Respiratory Disease Fellowsh

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medimmune (MM) (MEDI) Actualités

Medimmune (MM) (MEDI)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MEDI Actualités

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Receives Correspondence From FDA Regarding FluMist(R)

MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations

FDA Advisory Committee Recommends Expanded Use of FluMist(R)

Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

MedImmune Provides Fellowship Grants to Six Pediatric Respiratory Researchers

MedImmune and Pediatric Infectious Diseases Society Present 2007 Career Development Award and Viral Respiratory Disease Fellowsh

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités